Results 41 to 50 of about 7,242 (224)

Osteogenic Enhancement Between Icariin and Bone Morphogenetic Protein 2: A Potential Osteogenic Compound for Bone Tissue Engineering

open access: yesFrontiers in Pharmacology, 2019
Icariin, a typical flavonol glycoside, is the main active component of Herba Epimedii, which was used to cure bone-related diseases in China for centuries.
Xin Zhang   +7 more
doaj   +1 more source

Protection of Icariin Against Hydrogen Peroxide‐Induced MC3T3‐E1 Cell Oxidative Damage

open access: yesOrthopaedic Surgery, 2021
Objective The aim of the present study was to evaluate the potential protective mechanism of icariin against oxidative damage caused by hydrogen peroxide in MC3T3‐E1 cells.
Jian‐bin Sun, Zheng Wang, Wei‐jun An
doaj   +1 more source

Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis [PDF]

open access: yesJournal of Orthopaedic Surgery and Research, 2019
Abstract Background Osteoarthritis (OA) is the common chronic degenerative joint bone disease that is mainly featured by joint stiffness and cartilage degradation. Icariin (ICA), an extract from Epimedium, has been preliminarily proven to show anti-osteoporotic and anti-inflammatory effects in OA. However,
Yan Zu   +4 more
openaire   +3 more sources

Icariin-Curcumol promotes docetaxel sensitivity in prostate cancer through modulation of the PI3K-Akt signaling pathway and the Warburg effect

open access: yesCancer Cell International, 2023
Background Docetaxel (DTX) resistance reduces therapeutic efficacy in prostate cancer (PCa). Accumulating reports support the role of phytochemicals in the reversal of DTX resistance. This study aimed to determine whether Epimedium brevicornu and Curcuma
Wenjing Xu   +9 more
doaj   +1 more source

Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-γ-cyclodextrin

open access: yesFrontiers in Pharmacology, 2023
Icariin as a hepatoprotector from Herba epimedii can expand the cardiovascular and cerebral blood vessels, promote hematopoietic functions, enhance the immune system and show anti-liver tumor activities.
Yili Ding   +6 more
doaj   +1 more source

Icariin Is A PPARα Activator Inducing Lipid Metabolic Gene Expression in Mice

open access: yesMolecules, 2014
Icariin is effective in the treatment of hyperlipidemia. To understand the effect of icariin on lipid metabolism, effects of icariin on PPARα and its target genes were investigated.
Yuan-Fu Lu   +5 more
doaj   +1 more source

Icariin Enhances Bone Repair in Rabbits with Bone Infection during Post-infection Treatment and Prevents Inhibition of Osteoblasts by Vancomycin

open access: yesFrontiers in Pharmacology, 2017
Vancomycin is an effective antibiotic for treatment of bone infection caused by Staphylococcus aureus, however, a high local concentration of vancomycin might induce a delay in bone union.
Yang Zhang   +8 more
doaj   +1 more source

Inhibition of Th1 and Th17 Cells by Medicinal Plants and Their Derivatives: A Systematic Review. [PDF]

open access: yes, 2017
Searching for new natural drugs that are capable of targeting Th1 and Th17 may lead to development of more effective treatments for inflammatory and autoimmune diseases.
Asadi-Samani, Majid.   +3 more
core   +1 more source

Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma [PDF]

open access: yes, 2015
BACKGROUND: Extranodal NK/T-cell lymphoma (ENKL) is an aggressive hematological malignancy associated with Epstein–Barr virus (EBV) infection. It is often resistant to conventional chemotherapy and has a poor prognosis.
Bobin Chen   +8 more
core   +1 more source

Icariin ameliorates viral myocarditis by inhibiting TLR4-mediated ferroptosis

open access: yesAsian Pacific Journal of Tropical Biomedicine
Objective: To explore the mechanism by which icariin alleviates viral myocarditis. Methods: CVB3-induced cardiomyocytes were used as an in vitro model of viral myocarditis to assess the effects of icariin treatment on cell viability, inflammation, and ...
Wei Luo   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy